C. R. Cimochowski

Statistics

Publications

Citations

821

H-Index

Active since

1986

Affiliations

Pfizer (United States)(Current)

C. R. Cimochowski is an author at Pfizer (United States) specializing in pharmacology, antibacterial pharmacology, and pharmacokinetics of antimicrobials.

Publications per year

1986–1996

Publications

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

Agnès Girard, D Girard, A. R. English et al. · Antimicrobial Agents and Chemotherapy · 1987 · 323 citations

Medicine, Pharmacokinetics, Pharmacology +14

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.

G. Michael Bright, A. Nagel, Jon Bordner et al. · The Journal of Antibiotics · 1988 · 238 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute Infection

James A. Retsema, A. R. English, Agnès Girard et al. · Clinical Infectious Diseases · 1986 · 106 citations

Life Sciences, Microbiology, Pharmacology +17

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

Agnès Girard, D Girard, Thomas D. Gootz et al. · Antimicrobial Agents and Chemotherapy · 1995 · 72 citations

Medicine, Pharmacokinetics, Pharmacology +12

Correlation of increased azithromycin concentrations with phagocyte infiltration into sites of localized infection

Agnès Girard, C. R. Cimochowski, J. A. Faiella · Journal of Antimicrobial Chemotherapy · 1996 · 52 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +14

1–5 of 7